Advanced search - COVID-19 Research Repository - COVID-19 - Infectious diseases - Health protection - Population health - Public Health Scotland

Filter by publication date

From

Month Year

Test

To

Month Year

Test

Apply date filter

Showing 230 results

Application of a high-content screening assay utilising primary human lung fibroblasts to identify antifibrotic drugs for rapid repurposing in COVID-19 patients

Author

Marwick, John; Elliott, Richard; Longden, James; Makda, Ashraff; Hirani, Nikhil; Dhaliwal, Kevin; Dawson, John C.; Carragher, Neil O.

Source

Slas Discovery

Type

Journal article

Published

02 June 2021
Changes in availability, utilisation and prices of medicines and protection equipment for COVID-19 in an urban population of Northern Nigeria and the implications

Author

Haque, Mainul; Abubakar, Abdullahi Rabiu; Ogunleye, Olayinka O.; Sani, Ibrahim Haruna; Sefah, Israel; Kurdi, Amanj; Islam, Salequl; Godman, Brian

Source

Journal of Research in Pharmacy Practice

Type

Journal article

Published

13 May 2021
Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study

Author

Prats-Uribe, Albert; Sena, Anthony G.; Lai, Lana Yin Hui; Ahmed, Waheed-Ul-Rahman; Alghoul, Heba; Alser, Osaid; Alshammari, Thamir M.; Areia, Carlos; Carter, William; Casajust, Paula and 33 others

Source

BMJ

Type

Journal article

Published

11 May 2021
Non-steroidal anti-inflammatory drugs (NSAIDs) use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort

Author

Drake, Thomas M.

Source

The Lancet Rheumatology.

Type

Journal article

Published

07 May 2021
Cnicin as an anti-SARS-CoV-2: an integrated in silico and in vitro approach for the rapid identification of potential COVID-19 therapeutics

Author

Alhadrami, Hani A.; Sayed, Ahmed M.; Hassan, Hossam M.; Youssif, Khayrya A.; Gaber, Yasser; Moatasim, Yassmin; Kutkat, Omnia; Mostafa, Ahmed; Ali, Mohamed Ahmed; Rateb, Mostafa E. and 2 others

Source

Antibiotics

Type

Journal article

Published

07 May 2021
Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England

Author

Khunti, Kamlesh; Knighton, Peter; Zaccardi, Francesco; Bakhai, Chirag; Barron, Emma; Holman, Naomi; Kar, Partha; Meace, Claire; Sattar, Naveed; Sharp, Stephen and 5 others

Source

The Lancet Diabetes & Endocrinology

Type

Journal article

Published

01 May 2021
Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD

Author

Kennedy, Nicholas A.; Lin, Simeng; Goodhand, James R.; Chanchlani, Neil; Hamilton, Benjamin; Bewshea, Claire; Nice, Rachel; Chee, Desmond; Cummings, James; Fraser, Aileen and 16 others

Source

Gut

Type

Journal article

Published

26 April 2021
RSV genomic diversity and the development of a globally effective RSV intervention

Author

Kim, Sonnie; Williams, Thomas C.; Viboud, Cécile; Campbell, Harry; Chen, Jiani; Spiro, David J.

Source

Vaccine

Type

Journal article

Published

22 April 2021
Disparities in European healthcare system approaches to maintaining continuity of medication for non-communicable diseases during the COVID-19 outbreak

Author

Kardas, Przemyslaw; van Boven, Job Frank Martien; Pinnock, Hilary; Menditto, Enrica; Wettermark, Björn; Tsiligianni, Ioanna; Ágh, Tamás ; ENABLE Collaborators

Source

The Lancet Regional Health Europe

Type

Journal article

Published

14 April 2021
Hypoxic and pharmacological activation of HIF inhibits SARS-CoV-2 infection of lung epithelial cells

Author

Wing, Peter A.C.; Keeley, Thomas P.; Zhuang, Xiaodong; Lee, Jeffrey Y.; Prange-Barczynska, Maria; Tsukuda, Senko; Morgan, Sophie B.; Harding, Adam C.; Argles, Isobel L.A.; Kurlekar, Samvid and 13 others

Source

Cell Reports

Type

Journal article

Published

05 April 2021